1. Home
  2. ICU vs HOOK Comparison

ICU vs HOOK Comparison

Compare ICU & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • HOOK
  • Stock Information
  • Founded
  • ICU 2018
  • HOOK 2011
  • Country
  • ICU United States
  • HOOK United States
  • Employees
  • ICU N/A
  • HOOK N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • HOOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICU Health Care
  • HOOK Health Care
  • Exchange
  • ICU Nasdaq
  • HOOK Nasdaq
  • Market Cap
  • ICU 10.4M
  • HOOK 9.3M
  • IPO Year
  • ICU N/A
  • HOOK 2019
  • Fundamental
  • Price
  • ICU $1.18
  • HOOK $1.57
  • Analyst Decision
  • ICU
  • HOOK Buy
  • Analyst Count
  • ICU 0
  • HOOK 4
  • Target Price
  • ICU N/A
  • HOOK $10.67
  • AVG Volume (30 Days)
  • ICU 144.0K
  • HOOK 207.3K
  • Earning Date
  • ICU 05-14-2025
  • HOOK 05-15-2025
  • Dividend Yield
  • ICU N/A
  • HOOK N/A
  • EPS Growth
  • ICU N/A
  • HOOK N/A
  • EPS
  • ICU N/A
  • HOOK N/A
  • Revenue
  • ICU $428,000.00
  • HOOK $9,351,000.00
  • Revenue This Year
  • ICU $648.15
  • HOOK N/A
  • Revenue Next Year
  • ICU $100.00
  • HOOK N/A
  • P/E Ratio
  • ICU N/A
  • HOOK N/A
  • Revenue Growth
  • ICU N/A
  • HOOK N/A
  • 52 Week Low
  • ICU $1.11
  • HOOK $0.72
  • 52 Week High
  • ICU $13.85
  • HOOK $9.09
  • Technical
  • Relative Strength Index (RSI)
  • ICU 35.77
  • HOOK 59.01
  • Support Level
  • ICU $1.13
  • HOOK $1.51
  • Resistance Level
  • ICU $1.34
  • HOOK $1.62
  • Average True Range (ATR)
  • ICU 0.07
  • HOOK 0.15
  • MACD
  • ICU 0.00
  • HOOK -0.01
  • Stochastic Oscillator
  • ICU 23.81
  • HOOK 61.53

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.

Share on Social Networks: